VitaBreastCancer

VitaBreastCancer is a cutting-edge formulation developed to treat breast cancer, especially in early stages, by integrating phytocannabinoids into advanced nanoplatform technology. This innovative approach is designed to precisely target breast cancer cells, inhibiting tumor growth by modulating key molecular pathways involved in cancer progression. The formulation harnesses the therapeutic potential of cannabinoids such as CBD (cannabidiol), THC (tetrahydrocannabinol), CBG (cannabigerol), and CBC (cannabichromene), all of which have shown promising anti-cancer properties in preclinical studies, including reducing tumor size, inhibiting angiogenesis and metastasis, and inducing cancer cell apoptosis.